Successful treatment of infliximab-induced psoriasiform skin lesions despite biologic therapy intensification in a paediatric patient with Crohn's disease and primary sclerosing cholangitis

• Главные авторы: Agata Wasilewska (Автор), Małgorzata Chmielowska-Trybek (Автор), Małgorzata Sładek (Автор)
• Формат: ‌
• Опубликовано: Termedia Publishing House, 2021-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Therapy with infliximab (IFX), a tumour necrosis factor-α (TNF-α) inhibitor, has been demonstrated to be highly effective in several immune-mediated inflammatory diseases including Crohn's disease (CD) and psoriasis, both in adult and paediatric patients. With the increasingly widespread use an...